(Q34079562)

30 July 2017

1 reference

title

Tissue engineering via local gene delivery: update and future prospects for enhancing the technology (English)

1 reference

30 July 2017

1 reference

Bonadio J

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

Advanced Drug Delivery Reviews

30 July 2017

published in

1 reference

30 July 2017

volume

44

1 reference

30 July 2017

issue

2-3

1 reference

30 July 2017

page(s)

185-194

1 reference

Wound healing--aiming for perfect skin regeneration

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

1 reference

7 January 2021

Wound therapy: growth factors as agents to promote healing

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Protein stability in controlled-release systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Sustained delivery of proteins for novel therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Tissue engineering via local gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

DNA-polycation nanospheres as non-viral gene delivery vehicles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Stimulation of new bone formation by direct transfer of osteogenic plasmid genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

DNA delivery from polymer matrices for tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Nomenclature for synthetic gene delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Self-amplifying vectors for gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Application of membrane-active peptides for nonviral gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Nonviral gene therapy: promises and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Layer-by-layer deposition of oppositely charged polyelectrolytes on the surface of condensed DNA particles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Caged DNA does not aggregate in high ionic strength solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Quantitative assessment of DNA condensation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Self-assembly of DNA-polymer complexes using template polymerization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

pH-sensitive, cationic liposomes: a new synthetic virus-like vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

DNA vector chemistry: the covalent attachment of signal peptides to plasmid DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

PNA-dependent gene chemistry: stable coupling of peptides and oligonucleotides to plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

A potent new class of reductively activated peptide gene delivery agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Stability of peptide-condensed plasmid DNA formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Organ targeting in vivo using phage display peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Subcellular trafficking of the cytoplasmic expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Direct immunologic activities of CpG DNA and implications for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Mechanisms and therapeutic applications of immune stimulatory cpG DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

1 reference

7 January 2021

Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

AAV vectors: is clinical success on the horizon?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Viral receptors and vector purification: new approaches for generating clinical-grade reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Kinetics of recombinant adeno-associated virus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Rapid prototyping of patterned functional nanostructures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

A controlled-release microchip

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Translating biomolecular recognition into nanomechanics.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Medical ethics. Principles for human gene therapy studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Pharmacologic control of a humanized gene therapy system implanted into nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

Gene silencing as a threat to the success of gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900094-6

7 January 2021

10.1016/S0169-409X(00)00094-6

Identifiers

DOI

1 reference

30 July 2017

1 reference